Page last updated: 2024-11-05

tolmetin and Pain, Intractable

tolmetin has been researched along with Pain, Intractable in 8 studies

Tolmetin: A non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL) similar in mode of action to INDOMETHACIN.
tolmetin : A monocarboxylic acid that is (1-methylpyrrol-2-yl)acetic acid substituted at position 5 on the pyrrole ring by a 4-methylbenzoyl group. Used in the form of its sodium salt dihydrate as a nonselective nonsteroidal anti-inflammatory drug.

Pain, Intractable: Persistent pain that is refractory to some or all forms of treatment.

Research Excerpts

ExcerptRelevanceReference
" Ketorolac can be well tolerated in high-dose, long-term use even in this frail patient population."6.69The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome. ( Joishy, SK; Walsh, D, 1998)
" Ketorolac can be well tolerated in high-dose, long-term use even in this frail patient population."2.69The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome. ( Joishy, SK; Walsh, D, 1998)
" The administered dosage was 10 mg every 6 h for ketorolac and 50 mg every 8 h for diclofenac sodium."2.67Ketorolac versus diclofenac sodium in cancer pain. ( Corli, O; De Conno, F; Gallucci, M; Piva, L; Speranza, R; Tamburini, M; Toscani, F; Ventafridda, V, 1994)
"Ketorolac tromethamine is a newly available non-steroidal anti-inflammatory drug which is suitable for parenteral administration."2.67Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related pain. ( Myers, KG; Trotman, IF, 1994)
" In addition, the total daily dose of ketorolac was reduced following a change from intermittent bolus dosing to a continuous infusion."1.30Prolonged central intravenous ketorolac continuous infusion in a cancer patient with intractable bone pain. ( Gordon, RL, 1998)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toscani, F1
Piva, L1
Corli, O1
Gallucci, M1
Speranza, R1
Tamburini, M1
De Conno, F2
Ventafridda, V1
Myers, KG1
Trotman, IF1
Zecca, E1
Martini, C1
Ripamonti, C1
Caraceni, A1
Saita, L1
Middleton, RK1
Lyle, JA1
Berger, DL1
Hughes, A1
Wilcock, A1
Corcoran, R1
Gordon, RL1
Joishy, SK1
Walsh, D1
Staquet, MJ1

Reviews

1 review available for tolmetin and Pain, Intractable

ArticleYear
Ketorolac continuous infusion: a case report and review of the literature.
    Journal of pain and symptom management, 1996, Volume: 12, Issue:3

    Topics: Analgesics, Non-Narcotic; Humans; Infusions, Intravenous; Ketorolac; Male; Middle Aged; Pain, Intrac

1996

Trials

5 trials available for tolmetin and Pain, Intractable

ArticleYear
Ketorolac versus diclofenac sodium in cancer pain.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:4

    Topics: Adolescent; Adult; Aged; Analgesics; Diclofenac; Female; Humans; Ketorolac Tromethamine; Male; Middl

1994
Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related pain.
    Postgraduate medical journal, 1994, Volume: 70, Issue:823

    Topics: Adult; Aged; Drug Administration Schedule; Female; Humans; Infusion Pumps; Ketorolac Tromethamine; M

1994
Ketorolac: continuous subcutaneous infusion for cancer pain.
    Journal of pain and symptom management, 1997, Volume: 13, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Dose-Response Relationship, Drug; Drug Adm

1997
The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome.
    Journal of pain and symptom management, 1998, Volume: 16, Issue:5

    Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Colonic Ps

1998
A double-blind study with placebo control of intramuscular ketorolac tromethamine in the treatment of cancer pain.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:11

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Combinations; Female; Human

1989

Other Studies

2 other studies available for tolmetin and Pain, Intractable

ArticleYear
Tolerability of ketorolac administered via continuous subcutaneous infusion for cancer pain: a preliminary report.
    Journal of pain and symptom management, 1994, Volume: 9, Issue:2

    Topics: Adult; Aged; Analgesics; Female; Humans; Infusions, Parenteral; Ketorolac; Male; Middle Aged; Neopla

1994
Prolonged central intravenous ketorolac continuous infusion in a cancer patient with intractable bone pain.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:2

    Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cathet

1998